John Trnka, Thomas L Ely – Clinical Implications and Utility of Opioid Pharmacogenomics & AOA Update

In Stock

Original price was: $75.00.Current price is: $15.00.

[Instant Download] – Immediately deliver the download link after receiving the payment

Purchase this course you will earn 15 Points worth of $1.50!
Quantity

Buy John Trnka, Thomas L Ely – Clinical Implications and Utility of Opioid Pharmacogenomics & AOA Update Course at GBesy. We actively participate in Groupbuys and are committed to sharing knowledge with a wider audience. Rest assured, the quality of our courses matches that of the original sale page. If you prefer, you can also buy directly from the sale page at the full price (the SALEPAGE link is directly provided in the post).

[Instant Download] – Immediately deliver the download link after receiving the payment

John Trnka, Thomas L Ely – Clinical Implications and Utility of Opioid Pharmacogenomics & AOA Update course with special price just for you$75  $17

State Associations:
MOMS – Minnesota
Faculty:
John Trnka, PharmD, BCPS | Thomas L Ely, DO, FACOFP, FAAFP, DO, FACOFP, FAAFP
Duration:
2 Hours 01 Minutes
Expiration:
Never expires.

Description

  • Review current literature and guideline recommendations surrounding the use of pharacogenomics of pain management
  • Develop a pain management plan for a patient using pharmacogenomics
  • Disclosure:  The speakers have no actual or potential conflicts of interest in relation to this program and presentation.

    Handouts

    Faculty

    John Trnka, PharmD, BCPS's Profile

    John Trnka, PharmD, BCPS Related seminars and products: 1


    John is currently an inpatient clinical pharmacist with Mayo Clinic Health System in Mankato, MN. He earned his Doctor of Pharmacy degree from the University of Minnesota College of Pharmacy and completed a PGY-1 Pharmacy Practice residency at Mayo Clinic Health System in Mankato, MN. John’s practice interests include emergency medicine, pain management, and pharmacogenomics. 


    Thomas L Ely, DO, FACOFP, FAAFP, DO, FACOFP, FAAFP's Profile

    Thomas L Ely, DO, FACOFP, FAAFP, DO, FACOFP, FAAFP Related seminars and products: 4


    Dr. Ely is the current president of the American Osteopathic Association (AOA).  He is an AOA board-certified osteopathic family physician; a Fellow of the American Academy of Family Physicians, the American Association of Osteopathic Examiners, and the American College of Osteopathic Family Physicians.  A member of the AOA since 1980, he was elected to and served on the AOA’s Board of Trustees from 2006 – 2019, and represented Tennessee as a delegate or alternate delegate in the AOA’s House of Delegates from 1998 – 2019.  Dr. Ely also is past president of the Tennessee Osteopathic Medical Association and a member of the American College of Osteopathic Family Physicians.  He was appointed to the Tennessee Board of Osteopathic Examination (licensure board) for 9 years.  Prior to attending the Kansas City University of Medicine and Biosciences College of Osteopathic Medicine (KCUCOM) in Kansas City, MO, Dr. Ely served as a commissioned officer in the U.S. Army Medical Service Corps, which included two combat tours in Vietnam, serving as a “Dustoff” medical evacuation pilot.  Following osteopathic medical school, he re-entered the military as a commissioned officer in the U.S. Army Medical Corps and completed a family medicine internship and residency at DeWitt Army Community Hospital in Fort Belvoir, VA.  He retired from the Army in 1988 with the rank of  lieutenant colonel and went into private practice as a family physician in Clarksville, TN, and subsequently served as the Chief Medical Officer for the Gateway Medical Center in Clarksville from 2002 to 2015.


    Salepage: https://docme.ce21.com//item/clinical-implications-utility-opioid-pharmacogenomics-aoa-update-400546
    Archive: https://archive.ph/wip/APaW1

    Clinical Implications and Utility of Opioid Pharmacogenomics & AOA Update|John Trnka|Thomas L Ely|Thomas L Ely – Clinical Implications and Utility of Opioid Pharmacogenomics & AOA Update


    Buy the John Trnka, Thomas L Ely – Clinical Implications and Utility of Opioid Pharmacogenomics & AOA Update course at the best price at GBesy.. After your purchase, you will get access to the downloads page. You can download all the files associated in your order at here and we will also send a download notification email via your mail.

    Unlock your full potential with John Trnka, Thomas L Ely – Clinical Implications and Utility of Opioid Pharmacogenomics & AOA Update courses. our courses are designed to help you excel.

    Why wait? Take the first step towards greatness by purchasing John Trnka, Thomas L Ely – Clinical Implications and Utility of Opioid Pharmacogenomics & AOA Update courses today. We offer a seamless and secure purchasing experience, ensuring your peace of mind. With our trusted payment gateways, Stripe and PayPal, you can confidently complete your transaction knowing that your financial information is protected.

    Stripe, known for its robust security measures, provides a safe and reliable payment process. With its encrypted technology, your sensitive data remains confidential throughout the transaction. Rest assured that your purchase is protected.

    PayPal, a globally recognized payment platform, offers an additional layer of security. With its buyer protection program, you can feel confident in your purchase. PayPal ensures that your financial details are safeguarded, allowing you to focus on your learning journey.

    Is it secure? to Use of?
    How can this course be delivered?
    What Shipping Methods Are Available?
    How Do I Track Order?
    • We always notice the status of your order immediately after your payment. After 7 days if there is no download link, the system will automatically complete your money.
    • We love to hear from you. Please don’t hesitate to email us with any comments, questions and suggestions.

    Reviews

    There are no reviews yet.

    Be the first to review “John Trnka, Thomas L Ely – Clinical Implications and Utility of Opioid Pharmacogenomics & AOA Update”

    Your email address will not be published. Required fields are marked *

    Back to Top